{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:06:47Z","timestamp":1772464007165,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"vor","delay-in-days":318,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["307687\/2009-0"],"award-info":[{"award-number":["307687\/2009-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior"},{"name":"Rede Instituto Brasileiro de Neuroci\u00eancias","award":["01.06.0842-00"],"award-info":[{"award-number":["01.06.0842-00"]}]},{"name":"NENASC","award":["1262\/2012-9"],"award-info":[{"award-number":["1262\/2012-9"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.pbb.2014.12.009","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T07:20:50Z","timestamp":1419837650000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice"],"prefix":"10.1016","volume":"130","author":[{"given":"Vivian Binder","family":"Neis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana Meller","family":"Manosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Bainy","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.12.009_bb0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.12.009_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1007\/s40263-012-0030-1","article-title":"Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression","volume":"27","author":"Chang","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2014.12.009_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pscychresns.2014.01.003","article-title":"Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study","volume":"221","author":"Conway","year":"2014","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.pbb.2014.12.009_bb0025","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.pnpbp.2008.09.006","article-title":"Interaction of zinc with antidepressants in the tail suspension test","volume":"32","author":"Cunha","year":"2008","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(00)00332-0","article-title":"Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine","volume":"399","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0035","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1359786806064310","article-title":"Augmentation and combination strategies for depression","volume":"20","author":"DeBattista","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0028-3908(03)00199-0","article-title":"Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide","volume":"45","author":"Demehri","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.009_bb0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2014.07.024","article-title":"Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice","volume":"58","author":"Freitas","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pnpbp.2009.12.010","article-title":"Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system","volume":"34","author":"Freitas","year":"2010","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0065","first-page":"41","article-title":"Agmatine treatment is neuroprotective in rodent brain injury models","volume":"58","author":"Gilad","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.08.057","article-title":"Anxiolytic effect of agmatine in rats and mice","volume":"550","author":"Gong","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0075","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1749-6632.1999.tb09392.x","article-title":"Plasma agmatine and platelet imidazoline receptors in depression","volume":"881","author":"Halaris","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0080","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.12.009_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/372474","article-title":"The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial","volume":"12","author":"Hori","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.pbb.2014.12.009_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0026-895X(25)11243-1","article-title":"Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels","volume":"35","author":"Javitt","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0100","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder\u2014results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.pbb.2014.12.009_bb0105","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1526-4637.2010.00808.x","article-title":"Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Keynan","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.pbb.2014.12.009_bb0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-3999(02)00309-4","article-title":"Depression and immune function\u2014central pathways to morbidity and mortality","volume":"53","author":"Kiecolt-Glaser","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2013.03.019","article-title":"Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test","volume":"107","author":"Kotagale","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2014.12.009_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1023648923447","article-title":"Enhancement of antidepressant potency by a potentiator of AMPA receptors","volume":"23","author":"Li","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(03)01735-7","article-title":"Antidepressant-like effect of agmatine and its possible mechanism","volume":"469","author":"Li","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.12.009_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pnpbp.2013.06.012","article-title":"Antidepressant-like effect of alpha-tocopherol in a mouse model of depressive-like behavior induced by TNF-alpha","volume":"46","author":"Manosso","year":"2013","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2014.12.009_bb0145","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration","volume":"261","author":"Neis","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2014.12.009_bb0165","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bjp.0702679","article-title":"Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor","volume":"127","author":"Olmos","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0024-3205(03)00297-2","article-title":"Agmatine attenuates neuropathic pain in rats: Possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum","volume":"73","author":"Onal","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90516-9","article-title":"Antidepressant activity of noncompetitive and competitive NMDA \u00f5receptor antagonists in a chronic mild stress model of depression","volume":"263","author":"Papp","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0180","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s40263-012-0031-0","article-title":"Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder","volume":"27","author":"Patkar","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2014.12.009_bb0185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression\u2014clinical and preclinical studies","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pbb.2014.12.009_bb0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(25)24440-8","article-title":"Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2-adrenergic receptors","volume":"272","author":"Piletz","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2014.12.009_bb0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2011.02.024","article-title":"Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain","volume":"221","author":"Reus","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0210","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/jpet.105.086173","article-title":"Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse","volume":"314","author":"Roberts","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2014.12.009_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1996.tb00259.x","article-title":"Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks","volume":"79","author":"Rodrigues","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0220","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S1734-1140(13)71515-9","article-title":"Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy","volume":"65","author":"Rogoz","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2014.12.009_bb0225","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rogoz","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.009_bb0230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1196\/annals.1300.018","article-title":"Clinical studies implementing glutamate neurotransmission in mood disorders","volume":"1003","author":"Sanacora","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pbb.2014.12.009_bb0235","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2014.12.009_bb0240","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuropharm.2005.01.012","article-title":"Mechanisms involved in the antinociception caused by agmatine in mice","volume":"48","author":"Santos","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.009_bb0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1601-5215.2012.00675.x","article-title":"The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study","volume":"25","author":"Shopsin","year":"2013","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.pbb.2014.12.009_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0255","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/phrs.2000.0806","article-title":"Current perspectives on the development of non-biogenic amine-based antidepressants","volume":"43","author":"Skolnick","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test\u2014a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2014.12.009_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/WNF.0000000000000029","article-title":"Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs\u2014an open-label study","volume":"37","author":"Stryjer","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0270","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.009_bb0275","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainres.2006.02.024","article-title":"Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons","volume":"1084","author":"Wang","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2014.12.009_bb0280","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10571-007-9164-y","article-title":"Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence","volume":"28","author":"Wu","year":"2008","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0285","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(24)37988-1","article-title":"Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2014.12.009_bb0290","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2014.12.009_bb0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.03.027","article-title":"Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test","volume":"565","author":"Zeidan","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0300","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1023\/A:1025069407173","article-title":"Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells","volume":"23","author":"Zhu","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pbb.2014.12.009_bb0305","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","article-title":"Agmatine produces antidepressant-like effects in two models of depression in mice","volume":"13","author":"Zomkowski","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2014.12.009_bb0310","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","article-title":"Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test","volume":"1023","author":"Zomkowski","year":"2004","journal-title":"Brain Res"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714003475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714003475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T15:55:39Z","timestamp":1747324539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305714003475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":62,"alternative-id":["S0091305714003475"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.12.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}